Genezen Labratories, a viral vector production contractor for gene and cell therapy, is currently located in Launch Fishers and plans to open an R&D lab and clean manufacturing facility with office space in the Crosspoint business park. Genezen has committed to growing by 36 employees by 2024 and investing $7.8 million in capital improvements as part of their incentive package.
“We are extremely grateful to the City of Fishers and to the IEDC for making Fishers a supportive place to grow our business,” said Bill Vincent, CEO of Genezen Labs. “Gene and cell therapies have shown amazing potential in treating cancer and rare genetic disorders, but manufacturing capacity has proven to be a bottleneck in advancing these therapies to help patients. Genezen’s expansion will not only help alleviate this challenge but will provide an anchor for developing other gene therapy and biotech companies in central Indiana.”
The City of Fishers Common Council will consider real and personal property tax abatements for Genezen at the upcoming April Council meeting. The IEDC offered conditional tax credits based on the company’s job creation plans. These tax credits are performance-based, meaning the company is eligible to claim incentives once Hoosiers are hired.
About Genezen Labs
Genezen Labs works with companies to help them bring their gene therapies to market faster through established relationships with leading researchers and institutions, as well as contract viral vector manufacturing, testing, and transduced cell manufacturing.